menu
    • menu

    Company profile for Neumora therapeutics

    NEW Drugs in Dev: 6
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Neumora was founded to improve the lives of patients with brain diseases. A significant challenge is a lack of targeted, effective medicines.Neumora is relentless in its commitment to discovering, developing, and commercializing targeted therapies for people living with brain diseases. We believe a data science driven precision medicine approach to drug development will increase the probability of developing effective medicin...
    Neumora was founded to improve the lives of patients with brain diseases. A significant challenge is a lack of targeted, effective medicines.Neumora is relentless in its commitment to discovering, developing, and commercializing targeted therapies for people living with brain diseases. We believe a data science driven precision medicine approach to drug development will increase the probability of developing effective medicines.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Neumora therapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    65 Grove Street, Suite 102 Watertown, MA 02472
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://neumoratx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neumora
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/NeumoraTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neumora Therapeutics Joins Guggenheim Biotech Summit 2026
    Neumora Therapeutics Joins Guggenheim Biotech Summit 2026

    04 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/04/3231884/0/en/Neumora-Therapeutics-to-Participate-in-Guggenheim-Emerging-Outlook-Biotech-Summit-2026.html

    GLOBENEWSWIRE
    04 Feb 2026
    Share Share
    Neumora Therapeutics Reports Positive NMRA-511 Phase 1B Study
    Neumora Therapeutics Reports Positive NMRA-511 Phase 1B Study

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212566/0/en/Neumora-Therapeutics-Announces-Positive-Results-from-NMRA-511-Phase-1b-Signal-Seeking-Study-in-Alzheimer-s-Disease-Agitation.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Neumora Outlines 2026 Pipeline Strategy and Future Plans
    Neumora Outlines 2026 Pipeline Strategy and Future Plans

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3212570/0/en/Neumora-Therapeutics-Highlights-2026-Pipeline-Strategy-and-Anticipated-Upcoming-Milestones.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share
    Neumora Announces Initiation of Ph 1 Clinical Study of NMRA-898
    Neumora Announces Initiation of Ph 1 Clinical Study of NMRA-898

    27 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/27/3174424/0/en/Neumora-Therapeutics-Announces-Initiation-of-Phase-1-Clinical-Study-of-M4-Positive-Allosteric-Modulator-NMRA-898.html

    GLOBENEWSWIRE
    27 Oct 2025
    Share Share
    Neumora Therapeutics Shows Superior Weight Loss With NMRA-215
    Neumora Therapeutics Shows Superior Weight Loss With NMRA-215

    27 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/27/3174401/0/en/Neumora-Therapeutics-Announces-Class-Leading-Weight-Loss-Demonstrated-with-NMRA-215-in-Preclinical-Diet-Induced-Obesity-Model.html

    GLOBENEWSWIRE
    27 Oct 2025
    Share Share
    Neumora Therapeutics To Host Virtual R&d Day On October 27
    Neumora Therapeutics To Host Virtual R&d Day On October 27

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159334/0/en/Neumora-Therapeutics-to-Host-Virtual-R-D-Day-on-October-27.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search